What Is Cancer Immunotherapy? A Complete Guide
Medical disclaimer: This article is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified oncologist or immunotherapist to discuss options specific to your diagnosis.
If you or someone you love has been diagnosed with cancer, you’ve likely come across the term “immunotherapy” often described as one of the more significant developments in cancer treatment in recent decades. But what does it actually mean, how is it different from chemotherapy, and who is it right for? This guide breaks down cancer immunotherapy in plain language, from how it works to what a treatment course typically involves.
What Is Immunotherapy?
Immunotherapy is a category of cancer treatment that works by helping the body’s own immune system recognize and respond to cancer cells, rather than attacking the cancer directly the way chemotherapy or radiation does. Instead of introducing an external agent to destroy tumor cells, immunotherapy strengthens, redirects, or restores the immune system’s natural ability to identify cancer as a threat and act against it.
This distinction matters because it changes what the treatment is actually doing in the body — and it’s part of why immunotherapy is sometimes considered when other approaches have stopped working.
How Does Immunotherapy Work?
To understand immunotherapy, it helps to understand a basic fact about cancer: it starts with normal cells that mutate. The immune system is generally very good at identifying abnormal or mutated cells and destroying them before they cause harm. Cancer develops when mutated cells find ways to avoid detection essentially hiding from or suppressing the immune response so they can grow unchecked.
Immunotherapy works by countering that evasion in one of several ways:
- Removing the “brakes” cancer cells put on immune cells, so the immune system can recognize and attack them again.
- Marking cancer cells so immune cells can find and target them more precisely.
- Boosting the immune system’s overall activity, giving it a stronger response against abnormal cells.
- Training immune cells directly, using cells taken from the patient’s own body, to recognize a specific cancer’s markers.
Types of Cancer Immunotherapy Treatment
Immunotherapy isn’t a single treatment — it’s a category that includes several distinct approaches:
Checkpoint inhibitors Cancer cells often exploit natural “checkpoints” that immune cells use to avoid attacking healthy tissue. Checkpoint inhibitor drugs block these checkpoints, allowing immune cells to recognize and attack cancer cells that were previously going undetected.
Monoclonal antibodies These are lab-engineered antibodies designed to bind to specific markers on cancer cells, flagging them for the immune system to destroy — similar to how antibodies work against viruses and bacteria.
Cancer vaccines Unlike vaccines designed to prevent disease, therapeutic cancer vaccines are designed to trigger an immune response against cancer cells that are already present in the body.
Cytokine therapy Cytokines are signaling proteins that help regulate immune activity. Cytokine-based treatments aim to boost the immune system’s overall response to cancer.
Personalized, dendritic cell-based immunotherapy In this approach, specialized immune cells (dendritic cells) are extracted from a patient’s own blood, processed in a lab to help them recognize the specific characteristics of that patient’s cancer, and then reintroduced into the body. Because the treatment is built from the patient’s own cells, it’s inherently personalized to each individual’s specific cancer profile.
CAR T-cell therapy A newer, highly specialized form of immunotherapy where a patient’s T-cells are genetically modified to better recognize and attack cancer cells. It’s used for specific blood cancers and is currently more limited in availability than other immunotherapy types — availability should be confirmed directly with a specialist.
Recent Technology in Cancer Immunotherapy Treatment
Immunotherapy is one of the fastest-evolving areas of cancer care. Ongoing research continues to refine which patients respond best to which type of immunotherapy, often using biomarker testing to predict response before treatment even begins. Personalized approaches where treatment is built around an individual patient’s specific cancer and immune profile, rather than a standardized protocol represent the current direction of the field, moving away from one-size-fits-all treatment toward more tailored options.
It’s worth noting that immunotherapy remains an active area of clinical research. New techniques and combinations are continually being studied, and not every approach is available or appropriate for every cancer type a specialist can advise on what’s currently established versus still experimental for a specific diagnosis.
Immunotherapy vs. Chemotherapy vs. Radiation
| How it works | What it targets | |
| Chemotherapy | Kills rapidly dividing cells directly | Cancer cells (and some healthy fast-dividing cells) |
| Radiation | Uses targeted radiation to damage cancer cell DNA | A specific tumor location |
| Immunotherapy | Trains or enables the immune system to fight cancer | Cancer cells identified by the immune system |
Because immunotherapy works through a different biological mechanism, it’s sometimes used after chemotherapy or radiation have stopped being effective, alongside them, or — depending on the cancer type and stage as a primary approach. The right sequence depends entirely on the individual case.
What Cancers Can Immunotherapy Treat?
Immunotherapy is used across a range of cancer types, including bladder, brain, breast, cervical, lymphoma, ovarian, colorectal, head and neck, kidney, liver, lung, prostate, and skin cancers. That said, effectiveness varies significantly by cancer type, its specific genetic and molecular characteristics, and the individual patient it isn’t equally effective across all cancers or all patients, which is why testing and evaluation come before any treatment plan.
What to Expect During Immunotherapy Treatment
While specifics vary by treatment type, a general immunotherapy process typically includes:
- Diagnostic and biomarker testing to assess whether immunotherapy is a reasonable option for the specific cancer.
- Treatment planning, which may involve blood draws (for personalized, cell-based approaches) or scheduled infusions (for checkpoint inhibitors or antibody therapy).
- Treatment cycles, administered over weeks or months depending on the approach.
- Ongoing monitoring, since the immune system’s response needs to be tracked for both effectiveness and side effects.
Side Effects: What’s Different About Immunotherapy
Immunotherapy generally has a different side-effect profile than chemotherapy, since it isn’t designed to kill healthy dividing cells. Many patients report less of the nausea, hair loss, and severe fatigue commonly associated with chemotherapy. However, because immunotherapy increases immune activity, it can cause immune-related side effects inflammation in various organs, fatigue, or flu-like symptoms are possible, and these need to be monitored by a care team throughout treatment. “Different side effects,” not “no side effects,” is the accurate way to think about it.
Who Is a Candidate for Immunotherapy?
Candidacy depends on several factors evaluated by a specialist, including:
- The specific type and molecular profile of the cancer
- Biomarker test results indicating likely response
- Prior treatments already tried
- Overall health and immune system function
This is determined through direct consultation and testing not something to self-assess based on cancer type alone.
Benefits and Limitations of Immunotherapy
Potential benefits:
- Works through a different mechanism than chemotherapy, offering an option when other treatments stop working
- Personalized approaches are tailored to an individual’s specific cancer profile
- Generally different, and for many patients more manageable, side-effect profile compared to chemotherapy
Limitations to understand:
- Not effective for every cancer type or every patient
- Can still cause meaningful side effects that require monitoring
- Response varies significantly and cannot be guaranteed in advance
- Newer approaches like CAR T-cell therapy may have limited availability
A specialist can help set realistic expectations based on the specific diagnosis rather than general claims about the treatment category.
Choosing a Cancer Immunotherapy Specialist
When looking for an immunotherapist or cancer immunotherapy specialist, it’s worth considering their specific training in immunotherapy (not just general oncology), experience with your particular cancer type, and willingness to explain realistic outcomes rather than guarantees. Dr. Vikesh Shah, MBBS, MD (AIIMS, New Delhi), is a Cancer Immunotherapy Specialist based in Ahmedabad focused on personalized and targeted immunotherapy for a range of cancer types.
Common Myths About Cancer Immunotherapy
Because immunotherapy is widely discussed but not always well understood, a few misconceptions tend to come up in consultations:
Myth: Immunotherapy has no side effects. As covered above, immunotherapy’s side-effect profile is often different from and for many patients more manageable than chemotherapy, but it is not side-effect-free. Immune-related reactions are possible and require monitoring.
Myth: Immunotherapy works the same way for every cancer. Different cancers respond differently to different types of immunotherapy. A treatment that works well for one cancer type may not be appropriate for another, which is why biomarker testing and individual evaluation matter before starting treatment.
Myth: Immunotherapy is a last resort, only for when nothing else works. While immunotherapy is sometimes used after other treatments stop being effective, it’s increasingly used earlier in treatment plans for certain cancers, sometimes alongside chemotherapy or radiation rather than after them. The right timing depends on the specific case.
Myth: If immunotherapy works for one patient, it will work the same way for another with the “same” cancer. Two patients with the same general cancer diagnosis can have very different molecular and genetic profiles, and very different immune responses. This is exactly why personalized, biomarker-driven approaches are considered more reliable than a standardized protocol.
How Immunotherapy Fits Into a Broader Treatment Plan
Immunotherapy is rarely considered in isolation. A specialist typically looks at the complete picture cancer type and stage, genetic and biomarker testing results, prior treatments, and overall health before recommending immunotherapy alone, in combination with other treatments, or not at all for a given case. For some patients, immunotherapy becomes the primary treatment; for others, it’s used alongside chemotherapy, radiation, or surgery as part of a broader plan. This is also why an initial consultation typically involves a thorough review of prior medical records and test results, rather than a decision made from a single conversation.
Learn More About Your Options
Understanding immunotherapy is the first step the next is discussing whether it’s a reasonable option for your specific diagnosis. Book a consultation with Dr. Vikesh Shah to review your case and treatment options.
Frequently Asked Questions
What is the difference between immunotherapy and chemotherapy?
Chemotherapy directly kills rapidly dividing cells, including cancer cells. Immunotherapy works by helping the immune system recognize and attack cancer cells itself, using a different biological mechanism.
Is immunotherapy a new technology?
Immunotherapy has been researched for decades, but recent advances — particularly checkpoint inhibitors, personalized cell-based treatments, and biomarker testing — represent some of the newer technology in cancer treatment.
Does immunotherapy work for all types of cancer?
No. Effectiveness varies by cancer type and individual patient factors. Testing is used to help determine whether a specific cancer is likely to respond.
Is immunotherapy available in India?
Yes, immunotherapy is available in India, including personalized approaches offered by specialists such as Dr. Vikesh Shah in Ahmedabad.
Does immunotherapy have side effects?
Yes, though generally different from chemotherapy. Immune-related side effects are possible and are monitored throughout treatment by the care team.